#USA #Hamilton #radiopharmaceuticals #AtomVie #Jubilant Radiopharma

AtomVie Global Radiopharma Forms Strategic Alliance with Jubilant Radiopharma

In a significant development in the radiopharmaceutical sector, AtomVie Global Radiopharma, a renowned contract development and manufacturing organization (CDMO), has recently announced a strategic partnership with Jubilant Radiopharma. This collaboration is poised to enhance logistical and distribution capabilities specifically for clinical trials, addressing the growing demand for effective radiopharmaceutical solutions.

The partnership, formally structured under a comprehensive services agreement, is designed to bolster AtomVie’s current portfolio of radiopharmaceutical programs. Jubilant Radiopharma will be responsible for crucial logistics aspects such as handling, regulatory compliance, and last-mile distribution within their expansive pharmacy network across the United States. This endeavor aims to streamline the distribution process to clinical trial sites while ensuring adherence to stringent quality, safety, and regulatory standards required for radiopharmaceutical products.

Comments from Leadership

Bruno Paquin, the CEO of AtomVie, emphasized the importance of this partnership by stating, "As the radiopharmaceutical product sector continues to expand, robust logistics and distribution capabilities are essential to reliably and efficiently deliver products to patients and clinical centers." He expressed enthusiasm about the collaboration, noting that Jubilant Radiopharma's comprehensive pharmacy network, regulatory expertise, and commitment to quality make them an ideal partner. Paquin further highlighted how this alliance will enable AtomVie to enhance support for its clients' clinical development programs and establish the necessary infrastructure to advance future radiopharmaceutical therapies.

Harsher Singh, CEO of Jubilant Radiopharma, reiterated the commitment to provide safe and compliant access to radiopharmaceutical treatments throughout North America. He remarked, "As a trusted partner for therapeutic clinical trials and commercialization, we offer the specialized infrastructure, regulatory expertise, distribution capabilities, and national delivery network required to support radiopharmaceutical products through their entire lifecycle." Singh concluded by noting that the partnership with AtomVie underscores their shared commitment to accelerate innovation and broaden patient access to the next generation of therapeutic radiopharmaceuticals.

Strengthening Integrated Service Offerings

This partnership further solidifies AtomVie’s integrated service offerings. By leveraging Jubilant Radiopharma's well-established distribution infrastructure and specialized knowledge in clinical trials, therapeutic distribution, and commercialization, AtomVie anticipates improved access to clinical trial sites. Additionally, it allows for increased operational flexibility as development programs advance.

About AtomVie Global Radiopharma

Established as a frontrunner in the CDMO domain, AtomVie Global Radiopharma Inc. specializes in advancing the development and commercialization of radiopharmaceutical products. With state-of-the-art facilities spanning 72,300 square feet in Hamilton, Ontario, AtomVie delivers integrated solutions including process development, Good Manufacturing Practices (GMP) compliant manufacturing, quality control, regulatory support, and global distribution services for clinical and commercial programs.

About Jubilant Radiopharma

Jubilant Radiopharma, a prominent division of Jubilant Pharmova Limited, stands as a leader in the radiopharmaceutical sector, engaged in the development, manufacturing, distribution, and marketing of radiopharmaceutical products and services. Leveraging one of the largest radiopharmacy networks in the U.S., Jubilant Radiopharma supports diagnostic and therapeutic radiopharmaceutical programs by providing logistics services for clinical trials, regulatory assistance, and national distribution capabilities. With over 70 years of experience in the nuclear medicine community, Jubilant Radiopharma is dedicated to improving patient access to care and fostering innovation within the nuclear medicine field.

For further information, visit AtomVie and Jubilant Radiopharma.